RxDoctor Payments Data

Nedim Durakovic, MD

Otology & Neurotology · Creve Coeur, MONPI 1235492372

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $23,446 of the $25,658 with a category attached, or 91.4%. Cochlear Americas accounts for 96.9% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $22,538, more than ten times the $1,804 reported in 2019.

$25,658in general payments, 2019–2025

Across 35 payments — averaging $733.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$25K
  • Advanced Bionics, LLC$382
  • Med-el Corporation$250
  • Grace Medical, Inc.$118
  • KARL Storz Endoscopy-america$24
  • Medtronic$14
  • plus $14 from 1 others
$922in research payments, 2019–2025

Across 4 payments — averaging $230.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$922

What the payments were for

  • Consulting fees$6002%
  • Travel & lodging$23,44691%
  • Food & beverage$1,6136%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Missourito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$120,550
Medicare patients
408
Services billed
1,246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin143$5,332
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth50$5,043
Nortriptyline Hcl55$769
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid70$456
Gabapentin42$451
Venlafaxine Hcl ErVenlafaxine Hcl27$385
Methylprednisolone41$221
Ondansetron OdtOndansetron29$214
Diazepam30$132
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$112
Fluticasone Propionate14$111
Topiramate23$103
Prednisone23$85
Meclizine Hcl13$81
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$50

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Creve Coeur

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →